The development of HS donors, prodrugs, and molecules that can specifically target HS production pathways in a controlled and tissue-specific manner will be crucial for advancing clinical applications
However, the study lacked a placebo control, limiting interpretation (Kalamkar et al., Antioxidants, 2022) [55]
Tempesta E, Casella L, Pirrongelli C, Janiri L, Calvani M, Ancona L
Consequently, the available evidence does not support direct matching between specific antioxidants and ASD subtypes
L., Sly, W
Side effects are rare and typically minimal